Live Breaking News & Updates on Monty Kothiwale

World-leading Breast Cancer Oncologists Cynthia Ma MD, PhD and Massimo Cristofanilli, MD to Join Olaris Scientific and Medical Advisory Board
Share Article
Drs. Cynthia Ma and Massimo Cristofanilli to Advise on Biomarkers of Response (BoRs) to Drive Better Treatment Outcomes for Patients with Breast Cancer
I am impressed by Olaris’s technology and early data suggesting the potential use of a metabolomics signature as an independent and robust predictive biomarker in metastatic breast cancer. - Dr. Cristofanilli
WALTHAM, Mass. (PRWEB)
February 16, 2021
Olaris, Inc, a precision medicine company leveraging metabolomics and machine learning for the discovery and development of Biomarkers of Response (BoRs) to optimize treatments and patient outcomes, has appointed Dr. Cynthia Ma of Washington University in St. Louis and Dr. Massimo Cristofanilli from Northwestern Medicine to its Scientific Adv ....

United States , Stan Lapidus , Monty Kothiwale , Heliocos Biosciences , Gerhard Wagner , Massimo Cristofanilli , Cynthia Ma , Polaris Inc , Nuclear Magnetic Resonance , Molecular Pharmacology At Harvard Medical School , University Of Nebraska , Washington University In St , Translational Research , Cytyc Inc , Washington University , Northwestern Medicine , Scientific Advisory Board , Medical Advisory , Elizabetho Day , Chief Executive Officer , Olaris Advisory Board , Associate Director , Precision Medicine , Roberth Lurie Comprehensive Cancer Center , Northwestern University , Elkan Blout Professor ,